A low α-linolenic intake during early life increases adiposity in the adult guinea pig by Pouteau, Etienne et al.
RESEARCH Open Access
A low a-linolenic intake during early life increases
adiposity in the adult guinea pig
Etienne Pouteau
1*, Olivier Aprikian
1, Catherine Grenot
2, Denis Reynaud
3, Cecil Pace-Asciak
3, Claude Yves Cuilleron
2,
Eurídice Castañeda-Gutiérrez
1, Julie Moulin
1, Gregory Pescia
1, Carine Beysen
4, Scott Turner
4, Katherine Macé
1
Abstract
Background: The composition of dietary fatty acids (FA) during early life may impact adult adipose tissue (AT)
development. We investigated the effects of a-linolenic acid (ALA) intake during the suckling/weaning period on
AT development and metabolic markers in the guinea pig (GP).
Methods: Newborn GP were fed a 27%-fat diet (w/w %) with high (10%-ALA group), moderate (2.4%-ALA group)
or low (0.8%-ALA group) ALA content (w/w % as total FA) until they were 21 days old (d21). Then all animals were
switched to a 15%-fat diet containing 2% ALA (as total FA) until 136 days of age (d136).
Results: ALA and docosapentaenoic acid measured in plasma triglycerides (TG) at d21 decreased with decreasing
ALA intake. Total body fat mass was not different between groups at d21. Adipose tissue TG synthesis rates and
proliferation rate of total adipose cells, as assessed by
2H2O labelling, were unchanged between groups at d21,
while hepatic de novo lipogenesis was significantly 2-fold increased in the 0.8%-ALA group. In older GP, the 0.8%-
ALA group showed a significant 15-%-increased total fat mass (d79 and d107, p < 0.01) and epididymal AT weight
(d136) and tended to show higher insulinemia compared to the 10%-ALA group. In addition, proliferation rate of
cells in the subcutaneous AT was higher in the 0.8%-ALA (15.2 ± 1.3% new cells/5d) than in the 10%-ALA group
(8.6 ± 1.7% new cells/5d, p = 0.021) at d136. AT eicosanoid profiles were not associated with the increase of AT
cell proliferation.
Conclusion: A low ALA intake during early postnatal life promotes an increased adiposity in the adult GP.
Introduction
Worldwide, about 1.3 billion of individuals suffer of
excessive adiposity, 940 million are overweight and 400
million are obese [1]. This epidemic is driven by a wide-
spread energy imbalance, with energy intake exceeding
energy expenditure. Nevertheless, individual differences
in the susceptibility to gain an excess of fat mass, in
obesogenic environments exist. In addition to genetic
factors there is a growing body of evidence, from epide-
miological and animal studies, that perinatal nutrition
may substantially predispose to the development of obe-
sity. Fetal over and under-nutrition promotes adiposity
later in life in different animal models [2,3] and infants
small for gestational age appear to have a higher risk of
developing adult obesity [4]. Our understanding of the
factors and mechanisms, by which perinatal nutrition
impacts later susceptibility to obesity, remains limited.
Nevertheless, the early nutritional environment may set
a d i p o s et i s s u eg r o w t ha n df u n c t i o nt o w a r d se i t h e rf a t
storage or oxidation, later in life [5]. There is some evi-
dence that the composition of dietary fatty acids and
especially the essential polyunsaturated fatty acids
(PUFA), linoleic acid (LA; C18:2n-6) and a-linolenic
acid (ALA; C18:3n-3) and their respective long-chain
products, arachidonic acid (AA; C20:4n-6), eicosapentae-
noic acid (EPA; C20:5n-3) and docosahexaenoic acid
(DHA; C22:6n-3) influence early adipose tissue develop-
ment. These effects may be mediated by eicosanoids,
and more especially by prostaglandins (PG; PGD2, PGE2,
PGF2a,P G I 2), involved in adipose tissue growth and
metabolism and dependent on the long-chain PUFA
availability [6]. Animal studies showed that the intake of
a high LA/ALA ratio during fetal and postnatal life pro-
motes early adipose tissue growth and obesity [7,8].
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diet implies either a substantial increase of LA [8], a
decrease of ALA [7] or both [8], it is difficult to deter-
mine if the n-6 PUFA promote adipose tissue develop-
ment or if the n-3 PUFA have anti-adipogenic
properties. Because, the adipogenic effects of the n-6
PUFA remain controversial [9], we hypothesized that a
low level of ALA rather than an excess of LA leads to
an increased adiposity. In order to test part of this
hypothesis, 3 groups of newborn guinea pigs (GP) were
fed until 21 days of age with milk and pellets containing
either a high (10% total FA), medium (2.4% total FA) or
low but adequate (0.8% total FA) ALA content corre-
sponding respectively to a LA/ALA ratio of 2:1, 10:1
and 30:1. The short and long term consequences of
such early postnatal dietary interventions on adipose tis-
sue development and metabolic markers were
determined.
Materials and methods
Animals and diets
All experimental procedures were reviewed and
approved by the Swiss authorities ethical committee
(authorization 1910, “Service vetérinaire du canton de
Vaud”). Male and female Dunkin-Hartley guinea pigs
(450-500 g of body weight) were purchased from
Charles-River (Lyon, France) and housed together for
mating. The guinea pigs received a commercial chow
diet (Kliba 3420, Promivi Kliba SA, Kaiseraugst, Switzer-
land) during mating and gestation period. At birth, pups
remained with their dams for 2 days, and afterwards the
male pups were nourished with one of the following
27%-fat diets (w/w) differing in ALA content: 10%-ALA
(high), 2.4%-ALA (moderate) or 0.8%-ALA (low, w/w %
as total FA) until d21. From d2 to d4 the pups received
reconstituted milk formula and from d5 to d21 food pel-
lets. Milk formula and pellet composition is provided in
Table S1, Additional file 1 and the fatty acid profile is
detailed in Table S2, Additional file 2. From d21 to
d136, all guinea pigs received a 15%-fat diet based on
D22451 formulation (Research Diets, New Brunswick,
NJ). Coconut oil, corn oil, palm oil and rapeseed oil
(Sofinol S.A. Manno, Switzerland) were mixed with
ingredients of D224521 diet. Corn starch was added
(Schweizerhall Chemie, Basel, Switzerland) and lard,
soybean oil and maltodextrin were removed. The diet
contained 32.6% saturated fat, 39.2% monounsaturated
fat and 28.2% PUFA among them 26% LA and 2% ALA.
Twenty grams of timothy hay (Bio-Serv, Frenchtown,
NJ) was added weekly.
Study design
The male pups were randomized by body weight and
assigned to 10%-ALA group (n = 25), 2.4%-ALA group
(n = 20) or 0.8%-ALA group (n = 25) during the
suckling/weaning period until d21, and then all groups
were fed a common diet until the end of the experi-
ment. Body weight and food intake were recorded every
morning until d21 and then every 3 d until d136. Gui-
nea pigs were euthanized by exsanguination under iso-
fluorane anesthesia at d21 (10 pups for 10%-ALA and
0.8%-ALA groups and 5 pups for 2.4%-ALA group) and
at d136 (15 animals/group). Ten animals from 10%-ALA
and 0.8%-ALA groups received deuterated water (
2H2O)
for determination of cell proliferation and lipid synthesis
rate at d21 and d136 [10-12]. These animals received
2H2O (99%, sterilized 0.9% NaCl, 35 mg/g of BW) intra-
peritoneally 5 d before euthanasia, thereafter, they drank
8% deuterated water ad libitum until euthanasia. Blood
(200 μL) was collected from the aorta in heparinised
vials. Bone marrow from the femur of the hind limb
(flushed by 0.9%-NaCl-water using a 25G-needle-ser-
inge), adipose tissue, and liver were collected (about 50
mg) and weighed. All tissues and plasma were kept at
-80°C until analyses. Additionally and for the other ani-
mals, venous blood was collected from the saphenous
vein prior sacrifice for metabolite analyses. Retroperito-
neal, epididymal, interscapular and subcutaneous adi-
pose tissue, as well as the liver and the pancreas were
collected and weighed. The body composition of animals
was determined at regular intervals.
Analytical procedure
Fatty acid (FA) analysis
Total lipids of diet and plasma were extracted, and FA
profile of plasma phospholipids (PL) and TG was deter-
mined in 4 animals per group as previously described
[9].
Biochemical assays
Plasma TG, FFA and glucose concentrations were ana-
lyzed with commercially available kits (Roche Diagnos-
tic, Basel, Switzerland; Wako Chemicals, Richmond, VA
and Sigma, Buchs, Switzerland, respectively).
Guinea pig insulin purification and immunization
Guinea pig insulin was isolated from frozen pancreas
according to Yip & Ottensmeyer [13]. Purification was
improved by three successive chromatographies during
which the insulin-containing fractions were detected by
measurement of the radioactivity of 125I bovine insulin
added as tracer. The overall yield was 2.5 mg of purified
insulin per 20 pancreas of guinea pig. Degree of purity
of purified insulin was first controlled by reverse-phase
HPLC (300-5-C18 column, Macherey-Nagel, France)
that showed the presence of a major protein peak
(>90%) and by SDS-PAGE using the Schägger and von
Jagow method [14], adapted for the separation of low
molecular mass proteins and peptides (≤ 10 kDa). After
silver nitrate staining, the gel showed the presence of a
single intense band with an apparent mass of 6 kDa, in
agreement with the molecular mass of insulin. The
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mass spectrum of the purified fraction showed the pre-
sence of three multicharged [M+nH+] ions correspond-
ing to a single protein of molecular mass M of 5778.5,
in agreement with the mass of 5778.4, calculated for
guinea pig insulin. A radioactive insulin tracer was pre-
pared by radioiodination of 3 μg of purified insulin with
400 μCi of 125I iodine using the chloramine T method
in the conditions employed for the radiolabeling of
bovine insulin. Radiolabeled insulin was purified on
Sephadex G50 column and a fraction corresponding to
the top of the radioactive peak was collected and used
as tracer to test rabbit antibodies. Immunization of rab-
bits was initiated by 4 successive injections. After the
first six months of immunization titers of both rabbits
were measured at 1/10,000 and remained stable up to
now (one year of immunization). An estimation of the
specificity was done by the determination of cross-reac-
tivity with human, bovine, rabbit and mouse sera that
showed no cross-reaction with human, bovine and
mouse sera.
Radio-immunoassay (RIA) for guinea pig insulin
RIA was developed with rabbit antiserum incubated
with the radioactive 125I insulin tracer and different
concentrations of purified insulin as standard hormone.
The assay was performed with serum or plasma
obtained after collection of blood samples on EDTA.
Owing to the low concentrations observed in young gui-
nea pigs, the standard curve was established with eight
concentrations of standard insulin ranging from 0.5 to
100 ng.mL-1. The best standard curve was obtained
with an amount of 35’000-cpm/per tubes. Rabbit anti-
serum at a dilution of 1/10,000, were found to be suita-
ble for the establishment of the standard curve.
Incubation for 20 hours at 20°C led to the highest
bound fractions along with the lowest non-specific bind-
ing. The RIA program of the gamma counter was
employed using the LOGIT/log curve fitting. Reproduci-
bility and accuracy (spiking and dilution test) controls
were performed to assess of the values of insulin con-
centration. The RIA developed with rabbit antibodies
showed a sensitivity of 1 ng.mL
-1.
The pancreatic insulin content
The insulin was extracted from pancreas by acid-ethanol
solution at -20°C overnight [15]. The insulin content in
the supernatant was assessed by above developed RIA
method and expressed in ng.μg
-1 of protein.
Eicosanoid analysis
Adipose tissue (50 mg) was homogenized with distilled
ethanol (3 mL) as previously detailed [9]. The lipid
supernatant was then dried under nitrogen, dissolved
with 50 μL of ethanol/1 mL water and extracted with
ethyl acetate after acidification. The ethyl acetate extract
was dried and dissolved in acetonitrile/water for analysis
of eicosanoids by liquid chromatography-mass spectro-
metry (LC-MS/MS) using selected ion monitoring [9].
Determination of deuterium enrichments in DNA and lipids
T h em e a s u r eo f
2H-enrichments in DNA and in lipids
has been previously detailed [11,16,17]. Briefly, cellular
DNA from the adipose depot (> 20 mg of tissue) was
isolated. After sequential hydrolysis genomic deoxyri-
bose moiety was obtained from deoxyadenosine. Deox-
yribose was then acetylated into pentose-tetraacetate
derivative and analyzed by gas chromatograph/mass
spectrometer (GC/MS, Hewlett-Packard, Palo Alto, CA)
for measurement of
2H-isotope enrichments [17]. Sepa-
rately, adipose TG were isolated for analyses of
2H-
enrichments of TG-glycerol and of TG-palmitate by
GC/MS as described elsewhere [12,18-20]. Deuterium
enrichment in body water was measured from plasma
(20 μL) as described previously [21]. Standard curves of
known
2H-enrichments (EM1 in % excess) of the meta-
bolites were used to assess
2H-isotope enrichments [20].
Calculations of fractional synthesis rates
Use of
2H2O incorporation for the measurements of
DNA replication rate (cell proliferation rate), TG-gly-
cerol synthesis rate (all-source TG turnover) and TG-
palmitate synthesis rate (all-source DNL) has been
described [12,20]. The method counts the cell divisions
that occurred during the labeling period. The fractional
proliferation rate of adipose tissue cells (fractional
synthesis rate, FSRcell in % new cell/5 d) identical to the
fraction of newly synthesized DNA was calculated as the
2H-enrichment in adipose tissue DNA divided by
2H-
enrichment in bone marrow DNA [11,22]. The principle
for calculating the fractional synthesis rate of TG
(FSRTG) in adipose tissues is that TG that were synthe-
sized from endogenous alpha-glycerol phosphate before
2H2O was present, do not contain covalent C-
2Hl a b e l
in their glycerol moiety, thereby allowing the proportion
of newly synthesized vs. pre-existing TG to be assessed
[20]. Glycerol kinase in the liver overestimates the calcu-
lation of FSRTG in the liver. The FSRTG (in % new TG/5
d )w a sc a l c u l a t e df r o mt h er a t i oo fE M 1 TG to A1
 ,
where EM1TG is
2H-enrichment for glycerol at 5 d, and
A1
 is the maximal
2H-enrichment for glycerol [12].
The fractional synthesis rate of palmitate (DNL contri-
bution to palmitate, FSRpalmitate in % new palmitate/5 d)
in TG was calculated from the label
2H-incorporation
from water into TG-palmitate using MIDA (mass isoto-
pomer distribution analysis) [23].
Body composition
Body composition of pups was determined at 2, 21, 51,
79, 107 and 128 days of age using a 0.05-Tesla-Magnetic
Resonance Imaging (EchoMRITM 400, Echo Medical
Systems, Houston, TX, US). Calculation and interpreta-
tion were performed according to Taicher GZ [24] and
Tinsley FC [25].
Pouteau et al. Nutrition & Metabolism 2010, 7:8
http://www.nutritionandmetabolism.com/content/7/1/8
Page 3 of 9Statistical analysis
According to distribution of data, non-parameteric tests
were used for most outcomes (Global kruskal-Wallis
tests and Mann-Whitney-Wilcoxon tests for pairwise
comparisons). Outcomes were expressed as Median and
Standard Error of the Median (SEmedian) based on the
robust Sn of Rousseeuw. Comparisons of tissues based
on eicosanoids were done using Wilcoxon Signed Rank
tests. A low number of data on the FA profile was suffi-
cient to illustrate differences, although low number of
data involves cautious interpretation. A parametric
mixed model was used for NMR analysis, with subject
as random effect. These parameters are thus described
by the Mean and the Standard Error of the Mean
(SEM).
Results
Food intake was not different between groups. The
mean cumulative food intake was 118.1 ± 5.8 g (10%-
ALA), 124.6 ± 7.0 g (2.4%-ALA) and 125.1 ± 10.7 g
(0.8%-ALA group) from d9 to d18 and was 3013.3 ±
228.7 g (10%-ALA), 3138.6 ± 166.2 g (2.4%-ALA) and
3231.4 ± 119.9 g (0.8%-ALA group) from d23 to d129.
Fatty acid profile of plasma lipids was determined at
the end of the dietary intervention period (d21). Inclu-
sion of 10% ALA in the diet resulted in its increase in
plasma TG and PL (TG: 4.40 ± 0.35%; PL: 0.80 ± 0.26%,
figures 1A and 1B), but the increase was not significant
with the addition of 2.4% ALA (TG: 2.25 ± 0.23%; PL:
0.20 ± 0.01% and TG: 1.25 ± 0.37%; PL: 0.15 ± 0.07%
for 2.4% ALA and 0.8% ALA, respectively). The propor-
tion of total C20-22 n-3 PUFA, including eicosapentae-
noic acid (EPA), docosapentaenoic acid (DPA) and
docosahexaenoic acid (DHA), in plasma TG (figure 1A)
and PL (figure 1B) tended to decrease with decreasing
ALA intake, but this effect did not reach statistical sig-
nificance (p = 0.09 and p = 0.07 for PL and TG, respec-
tively), except for DPA in TG and for EPA in PL. The
0.8%-ALA group (0.01 ± 0.01 mol %) had lower DPA in
TG than both other groups (2.4%-ALA: 0.20 ± 0.12, p <
0.05 and 10%-ALA: 0.20 ± 0.01 mol %, p = 0.06). For
EPA in PL, there was a significant difference between
10%-ALA group (0.10 ± 0.01 mol %) and 0.8%-ALA
group (0.01 ± 0.01 mol %, p = 0.018). As expected,
there was no difference in plasma LA between groups
and increasing ALA intake did not modify the propor-
tion of n-6 PUFA (figures 1C and 1D).
The body weight (BW; 10%-ALA: 869.3 ± 54.2 g;
2.4%-ALA: 860.7 ± 29.6 g and 0.8%-ALA group: 902.3 ±
25.7 g at d136) and BW gain (data not shown) did not
differ between groups during the course of the
experiment.
Decreased intake of ALA during early life resulted in
increased body fat at 136 days; Figure 2 shows the fat
mass evolution during the course of the study expressed
as g (figure 2A) or % body weight (figure 2B). While no
differences were observed at the end of the dietary inter-
vention period (d21), older guinea pigs in the 0.8%-ALA
group had or tended to have more fat mass than those
in the 10%-ALA group at d79 (figure 2A: +20.3 g, p =
0.08; figure 2B: +2.6%, p < 0.01), at d107 (+29.9 g, p <
0.05; +2.8%, p < 0.01) and at d128 (+22.6 g, p = 0.05;
+1.7%, p = 0.08) and than those in the 2.4%-ALA group
at d128 (+24.2 g, p < 0.05; +2.2%, p < 0.05).
Likewise, at d 136, epididymal AT was or tended to be
heavier in the 0.8%-ALA than in the 10%-ALA (+0.19 g/
100 g BW, p < 0.05) and the 2.4%-ALA group (+0.16 g/
100 g BW, p = 0.05). The interscapular AT weight also
was higher in the 0.8% than in the 2.4%-ALA groups
(+0.18 g/100 g BW, p < 0.01). The weights of epididy-
mal, interscapular and retroperitoneal AT relative to
BW were not different between groups at d21 (Table
S3, Additional file 3). The liver weight as well as the
pancreas weight did not differ between groups at d21
and d136 (data not shown).
The fractional proliferation rates (FSR) of cells, mea-
sured in the retroperitoneal and epididymal AT, were
unchanged between 10%-ALA and 0.8%-ALA groups at
both d21 and d136 (Table 4, Additional file 4). Nonethe-
less, the cell proliferation rate in the subcutaneous AT
was higher in the 0.8%-ALA group compared to the
10%-ALA group at d21 (2.1-fold higher; not significant)
and d136 (1.8-fold higher; p = 0.021) (Table 4, Addi-
tional file 4).
T h ed en o v ol i p o g e n e s i s( D N L )a n ds y n t h e s i sr a t eo f
TG in the different adipose fat pads did not differ
between the 10%- and 0.8%-ALA groups at d21 (Table
5, Additional file 5). A higher hepatic DNL (P < 0.001)
was observed at d21 in guinea pigs fed 0.8%-ALA intake
compared to 10%-ALA intake (Table 5, Additional file
5). No difference was observed in DNL or synthesis rate
of TG in hepatic or adipose tissues between groups at
d136 (Table 5, Additional file 5).
The arachidonic acid (AA) a n dm o s te i c o s a n o i dc o n -
centrations determined in retroperitoneal and subcuta-
neous fat pads were not different between the groups
(Table 6, Additional file 6). An exception was observed
for PGE2 and PGJ2 that were both significantly higher
after medium vs low ALA intake at d136 (Table 6,
Additional file 6). In order to evaluate the AT differ-
ences, the groups were combined and the eicosanoid
profile was compared between the fat depots at both
ages. At d21, AA, 6-keto-PGF1a and PGJ2 concentra-
tions were 1.6-fold (244.7 ± 24.9 vs 149.6 ± 14.0 ng/50
mg AT, p < 0.01), 3.7-fold (1.95 ± 0.10 vs 0.52 ± 0.09
ng/50 mg AT, p < 0.0001) and significantly (0.015 ±
0.001 vs 0.001 ± 0.001 ng/50 mg AT, p < 0.0001) higher
in the retroperitoneal AT when compared to the
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of PGJ2 concentrations was even higher between the ret-
roperitoneal (1.53 ± 0.35 ng/50 mg AT) and subcuta-
neous (0.01 ± 0.01 ng/50 mg AT, p < 0.0001) AT. In
addition, 6-keto-PGF1a,P G E 2 and PGF2a were 1.5-fold
(p < 0.001), 23-fold (p < 0.0001) and 1.6-fold (p <
0.0001) higher in the retroperitoneal vs subcutaneous
AT (data not shown).
The plasma FFA were not different between groups at
d21 (data not shown) or at d136 (10%-ALA, 17.6 ± 0.7;
2.4%-ALA, 18.0 ± 0.6 and 0.8%-ALA group, 18.0 ± 1.1
mg.dL
-1). The plasma TG concentrations were
unchanged at d21 (data not shown) but were 1.3-fold
lower in the 0.8%-ALA vs 10%-ALA (1.31 ± 0.05 vs 1.78
± 0.21 mmol.L
-1,p<0 . 0 5 )a n dv s2 . 4 % - A L Ag r o u p
(1.61 ± 0.15 mmol.L
-1, not significant), at d136. There
were no differences in plasma insulin concentrations
between groups at the end of the suckling/weaning
period (figure 3A). At d136 (figure 3B) the 0.8%-ALA
group (6.8 ± 1.5 ng.mL
-1)s h o w e da b o u t1 . 5 - f o l dh i g h e r
concentrations of plasma insulin when compared with
other groups (2.4%-ALA, 4.3 ± 1.3 and 10%-ALA group,
5.1 ± 1.7 ng.mL
-1, not significant). Similar results were
observed regarding the pancreatic insulin content. The
0.8%-ALA group showed about 1.6-fold increase in the
pancreatic insulin content (3.5 ± 0.8 ng.μg
-1 of protein)
when compared to the 10%-ALA group (2.2 ± 0.3 ng.μg
-
1 of protein, p = 0.06, not significant) at d136 (figure
3B). There were no significant differences in plasma glu-
cose between groups at d21 (data not shown) and
neither at d136 (10%-ALA, 112.0 ± 3.3; 2.4%-ALA, 110.0
± 6.7 and 0.8%-ALA group, 104.5 ± 4.6 mg.dL
-1).
Discussion
To our knowledge this is the first study showing that
dietary ALA intake during the suckling/weaning period
Figure 1 Fatty acid composition (mol %) of plasma triglycerides (TG) and phospholipids (PL) at d21. Proportion of ALA and total other
long-chain n-3 PUFAs (C20:3n-3, C20:5n-3, C22:5n-3, C22:6n-3) in plasma TG (A) and PL (B). Proportion of LA and total other long-chain n-6
PUFAs (C20:2n-6, C20:3n-6, C20:4n-6, C22:2n-6, C22:4n-6) in plasma TG (C) and PL (D). Data are medians ± SEmedian, n = 4-5 samples/group in
duplicate. LA, linoleic acid; ALA, alpha-linolenic acid. * p < 0.05, ** p < 0.01, *** p < 0.001 between groups.
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dietary ALA intake programming the highest adiposity
in the adult guinea pig.
In our study, the adipose tissue development was not
impacted during the period of dietary intervention with
different ALA levels. Indeed, the fat mass and adipose
t i s s u ew e i g h ta td 2 1w e r en o td i f f e r e n tb e t w e e nt h e
high, moderate and low ALA fed guinea pigs. Our
results are in agreement with Korotkova et al.w h o
showed that offspring of rat dams, fed a 6.2% ALA
(total FA) enriched diet during the gestation and suck-
ling period, did not differ in AT weight at 3 weeks of
age compared to a low ALA diet with the same amount
of dietary lipids [8]. On the contrary, the dietary intake
of chia seed (rich in ALA) decreased adiposity in adult
r a t sf e da no b e s e g e n i cd i e t[ 2 6 ] .I n t e r e s t i n g l yt h i se f f e c t
was associated with a large increase in plasma lipid n-3
LC-PUFAs (EPA and DHA), known to have anti-adipo-
genic effects [27], probably through inhibition of the
proliferation of adipose tissue cells [27]. While no one
can exclude that ALA has its own specific physiological
effects on AT development, it is tempting to speculate
that these effects are more dependent on its long-chain
products. Unlike other rodents and similarly to humans,
the efficiency of ALA conversion into its long-chain pro-
ducts is limited in guinea pigs [28]. As previously shown
in AT and other tissues of the guinea pigs [29], we
observed in our study a higher ALA proportion in
plasma TG and phospholipids with an increasing ALA
intake but with a limited increase of >C20 n-3 PUFA.
Indeed, EPA, DPA or DHA represents less than 0.8% of
Figure 2 Fat mass evolution. (A) Fat mass (g) evolution from d21
to 128. (B) Fat mass (% of body weight) at 21, 79, 107 and 128
days. Data are means ± SE, n = 15-20 guinea pigs/group.
+ indicates
p < 0.05 between the 0.8%-ALA and 2.4%-ALA or 10%-ALA groups.
* indicates p < 0.05 and ** indicates p < 0.01 between the 0.8%-
ALA and 10%-ALA groups.
Figure 3 Plasma insulin concentrations and pancreatic insulin
contents. (A) Plasma insulin at d21, n = 5 guinea pigs/group. (B)
Plasma and pancreas insulin at d136, n = 10-15 guinea pigs/group.
Data are medians ± SEmedian, no significant difference.
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ALA intake, and could explain the absence of impact on
the adipose tissue development of the 21-day old guinea
pigs. Previous studies have indicated that n-3 LC-PUFAs
enriched diets diminish the hepatic enzymatic activities
of endogenous fatty acids synthesis [30] associated with
ad e c r e a s ei np l a s m aT G[ 3 1 , 3 2 ] .I nt h ep r e s e n ts t u d y ,
the high ALA intake induced a 2-fold reduction of frac-
tional DNL in the liver at d21 with no impact on total
plasma TG concentration. A higher >20 n-3 PUFA
plasma concentration during the high ALA intake could
modulate transcription factors in the liver. It is possible
that that >20 n-3 PUFAs reduce DNL by down-regulat-
ing SREBP-1 (sterol regulatory element-binding protein-
1) and activating PPAR alpha (peroxisome proliferator-
activated receptor alpha) as shown by previous studies
[33]. To explain no difference on total plasma TG, we
considered that fatty acids for TG synthesis come from
t h eD N L ,t h ed i e t a r ys o u r c eo rf r o mt h ea d i p o s et i s s u e
lipolysis. Based on the calculation of the FA contribu-
tion from DNL to TG synthesis (ratio of DNL to TG
FSR), we estimated that the contributions from the diet-
ary source plus the adipose tissues were 72% and 87%
for the low and high ALA groups, respectively [10].
Since dietary FA contributed equally between groups,
plasma TG containing FA from the adipose tissue may
have been greater in the high ALA group compared
with low ALA group at d21. It is possible that more
plasma TG containing FA from the adipose tissue was
utilized by the liver or muscle (e.g. for oxidation).
Further analysis of VLDL-TG (very large density lipo-
protein-TG) secretion and removal rates in and from
the circulation could clarify the unchanged plasma TG.
Ultimately the fat mass was unchanged between the
groups at the end of the suckling/weaning diet
treatment.
The long-term adipogenic effect of a low ALA intake
during early postnatal life seems to be more pronounced
on subcutaneous than visceral AT. Indeed, the 2 to 3%
differences of total fat mass found between the low and
high ALA group at d107 and d128 may not be explained
by the observed difference of epididymal fat pad weights,
knowing that the visceral fat depots (calculated by sum-
ming the weight of epididymal, retroperitoneal and
mesenteric AT) represent only about 18% of total fat
mass in the adult GP. The subcutaneous adipose tissue
which represents the major fat depot in adult (about
80%) revealed a significant increase in cell proliferation
in adults after the 0.8% ALA versus 10% ALA postnatal
diet treatment. No hyperplasia was noticed in other fat
depots after 0.8% ALA intake. This supports a specific
role of the subcutaneous adipose tissue. Previous studies
indicated a direct effect of n-3 fatty acid enriched diet
on decreasing adipocyte differentiation and increasing
apoptosis in vitro [34] and in high-fat fed rats [35]. In
the present study, we could not measure the deuterium
enrichment decay in DNA to determine the apoptosis
rate that could have been lowered in subcutaneous AT
of the adult GP of low ALA group. On the contrary, we
observed a clear imprinted effect of low ALA early
intake on increasing the cell proliferation rate by 75%
versus high ALA early intake in the subcutaneous AT of
adult GP. In addition, we showed a transient increase of
hepatic DNL in the low ALA group at d21 that could
be involved in the imprinting mechanism. Further inves-
tigations are needed to clarify the mechanism.
Interestingly, the 0.8% ALA group had higher insulin
at the end of the experiment, though the differences
between groups did not reach statistical significance due
to a high variability. This tendency for higher insuline-
mia is probably linked to an increased adiposity, as
known for other animal species and human. We found a
positive correlation between insulin (expressed as log)
and fat mass in the adult guinea pigs (Pearson r = 0.77,
p < 0.0001). Although all in a normal range [36], plasma
TG were significantly higher in the high versus medium
and low ALA groups at d136. This was not associated
with an increased adipose tissue FSR of total TG in the
high ALA group. Previous studies showed the capabil-
ities of n-3 LC-PUFAs to modulate lipolysis and conse-
quently alter TG level [27,37]. Although we described a
possible imprinted effect in the present study, the
increased plasma TG could be due to an increased lipo-
lysis to support a lower fat mass in the adult GP of high
ALA group.
The mechanism by which a low ALA intake programs
an excess of adipose tissue is unclear. It may imply cell
proliferation as indicated in the present study by the
increase of fractional proliferation rate of cells in the
subcutaneous AT. Because eicosanoids are modulated
by LC-PUFAs and are involved in the differentiation
and proliferation of adipose tissue cells we expected to
see differences between groups [38]. Beside the large dif-
ferences between the types of fat depots (visceral vs sub-
cutaneous) on eicosanoid levels, we found only minor
changes between groups and none in subcutaneous AT.
Further studies are definitely needed to understand the
mechanism by which early dietary ALA impacts adipo-
genesis and lipogenesis later in life. The Guinea Pig
represents a good model to the human term newborn
[39] but shows some experimental limitations due to the
lack of commercially available immunological kits and
epigenetic markers. This may change with the recent
first release of the genome sequencing and assembly of
the Guinea Pig [40]. Future investigations using the Gui-
nea Pig model will help understanding the mechanisms
by which early nutrition may program adiposity later in
life. It would be also interesting to evaluate whether the
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more pronounced with dietary interventions including
gestation and/or with more obesogenic post-weaning
diets (e.g., high fat/high sucrose diet).
Our main finding shows that a suboptimal ALA intake
during suckling/weaning promotes the susceptibility to
an increased adiposity later in life. It is important to
note that the ALA diet (0.8% total FA; 0.16 g ALA/100
g diet), used for the low intake group, does not corre-
spond to a deficient diet (0.01 g/100 g diet) as pre-
viously described [41]. Interestingly, smoking mothers
have lower ALA content in breast milk than non-smok-
ing ones [42] and maternal smoking is associated with
an increased risk of late onset overweight [43]. Conse-
quently, if relevant to the human newborn, our findings
suggest the need of recommending n-3 PUFA supple-
mentation in the pregnant/lactating mother with a low
ALA intake or at risk of suboptimal breast milk content.
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S1.DOC]
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one table.
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S2.DOC]
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weight) at d21 and d136”. The file contains one table.
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S3.DOC]
Additional file 4: Table S4 on “Fractional proliferation rate of cells
(in % new cells/5 days) in adipose tissue (AT) at d21 and d136”. The
file contains one table.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1743-7075-7-8-
S4.DOC]
Additional file 5: Table S5 on “De novo lipogenesis (DNL) and
fractional synthesis rate (FSR) of TG in the liver and adipose tissues
(AT) at d21 and d136”. The file contains one table.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1743-7075-7-8-
S5.DOC]
Additional file 6: Table S6 on “Eicosanoid and AA concentrations
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and d136”. The file contains one table.
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